InspireMD to Report Third Quarter 2018 Financial Results and Provide Business Update on Tuesday, November 6

Conference Call Scheduled for 8am Eastern Time

Tel Aviv, Israel— October 30, 2018 – InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of carotid artery disease, announced today that it will host a conference call and webcast on Tuesday, November 6, 2018, to discuss financial results for the three and nine  months ended September 30, 2018, and provide a corporate update.

Conference Call & Webcast:
Tuesday, November 6 @ 8:00am Eastern Time
Within the US:                                   877-451-6152
Outside the US:                                 201-389-0879
Conference ID:                                  13683949

Replays, Available through November 20:                                             
Domestic:                                            844-512-2921
International:                                    412-317-6671
Replay PIN:                                         13683949

About InspireMD, Inc.
InspireMD seeks to utilize its proprietary MicroNet™® technology to make its products the industry standard for treatment of carotid arter disease by providing outstanding acute results and durable stroke free long-term outcomes.

InspireMD’s common stock is quoted on the NYSE American under the ticker symbol NSPR and certain warrants are quoted on the NYSE American under the ticker symbol NSPR.WS.

Investor Contacts:
Craig Shore
Chief Financial Officer
InspireMD, Inc.

Jeremy Feffer
LifeSci Advisors, LLC